Cargando…

Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge

Evidence supports a role of complement anaphylatoxin C5a in the pathophysiology of COVID-19. However, information about the evolution and impact of C5a levels after hospital discharge is lacking. We analyzed the association between circulating C5a levels and the clinical evolution of hospitalized pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senent, Yaiza, Inogés, Susana, López-Díaz de Cerio, Ascensión, Blanco, Andres, Campo, Arantxa, Carmona-Torre, Francisco, Sunsundegui, Patricia, González-Martín, Antonio, Ajona, Daniel, Okrój, Marcin, Prósper, Felipe, Pio, Ruben, Yuste, José Ramón, Tavira, Beatriz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636747/ https://www.ncbi.nlm.nih.gov/pubmed/34868021 http://dx.doi.org/10.3389/fimmu.2021.767376

Ejemplares similares

C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d
por: Kowalska, Daria, et al.
Publicado: (2022)

The Complement System in Ovarian Cancer: An Underexplored Old Path
por: Senent, Yaiza, et al.
Publicado: (2021)

Complement in Metastasis: A Comp in the Camp
por: Ajona, Daniel, et al.
Publicado: (2019)

Complementing the Cancer-Immunity Cycle
por: Pio, Ruben, et al.
Publicado: (2019)

Complement C4d-specific antibodies for the diagnosis of lung cancer
por: Ajona, Daniel, et al.
Publicado: (2017)

Editorial: Complement and Immunotherapeutics
por: Okrój, Marcin, et al.
Publicado: (2021)

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
por: Aparicio, Belén, et al.
Publicado: (2021)

Complement Activation as a Helping Hand for Inflammophilic Pathogens and Cancer
por: Okrój, Marcin, et al.
Publicado: (2019)

Editorial: Expert opinions and perspectives in complement: 2022
por: Okrój, Marcin, et al.
Publicado: (2023)

Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
por: Hsu, Yi-Fan, et al.
Publicado: (2010)

MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
por: Soldevilla, Mario Martínez, et al.
Publicado: (2016)

Functional Analyses of Complement Convertases Using C3 and C5-Depleted Sera
por: Okroj, Marcin, et al.
Publicado: (2012)

Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
por: Okrój, Marcin, et al.
Publicado: (2016)

CD28 Aptamers as Powerful Immune Response Modulators
por: Pastor, Fernando, et al.
Publicado: (2013)

Immunologic Characterization of Coronavirus Disease 2019 (COVID-19) Patients with Hematological Cancer: Biologic and Clinical Significance
por: Maia, Catarina, et al.
Publicado: (2020)

Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2021)

Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)
por: Soldevilla, Mario Martínez, et al.
Publicado: (2017)

IMMU-09. MODULATING THE MYELOID POPULATION IN DIPG MODELS WITH ONCOLYTIC VIRUS AND COMPLEMENT INHIBITORS SHOWS THERAPEUTIC EFFICACY
por: Puigdelloses, Montserrat, et al.
Publicado: (2021)

The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis
por: Struglics, André, et al.
Publicado: (2016)

Elevated Levels of the Complement Activation Product C4d in Bronchial Fluids for the Diagnosis of Lung Cancer
por: Ajona, Daniel, et al.
Publicado: (2015)

Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
por: Felberg, Anna, et al.
Publicado: (2019)

In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies
por: Urban, Aleksandra, et al.
Publicado: (2022)

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
por: Redin, Esther, et al.
Publicado: (2021)

Editorial: The Role of Complement in Tumors
por: Rolfe, Barbara E., et al.
Publicado: (2020)

Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
por: Felberg, Anna, et al.
Publicado: (2020)

Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma
por: Casales, Erkuden, et al.
Publicado: (2021)

Immunologic characterization of COVID-19 patients with hematological cancer
por: Maia, Catarina, et al.
Publicado: (2020)

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
por: Inogés, Susana, et al.
Publicado: (2017)

Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
por: Escudero-Esparza, Astrid, et al.
Publicado: (2016)

Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
por: Escudero-Esparza, Astrid, et al.
Publicado: (2023)

Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy
por: López-Díaz de Cerio, Ascensión, et al.
Publicado: (2021)

Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis
por: Santisteban, Marta, et al.
Publicado: (2021)

Controversies around the statistical presentation of data on mRNA-COVID 19 vaccine safety in pregnant women
por: Bartoszek, Krzysztof, et al.
Publicado: (2022)

A model based on the quantification of complement C4c, CYFRA 21–1 and CRP exhibits high specificity for the early diagnosis of lung cancer
por: AJONA, DANIEL, et al.
Publicado: (2021)

Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases
por: Michels, Marloes A. H. M., et al.
Publicado: (2018)

Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies
por: Mejías Sosa, Luis, et al.
Publicado: (2023)

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
por: Larrayoz, Marta, et al.
Publicado: (2014)

Substitutions at position 263 within the von Willebrand factor type A domain determine the functionality of complement C2 protein
por: Kuźniewska, Alicja, et al.
Publicado: (2022)

Vaccination with LytA, LytC, or Pce of Streptococcus pneumoniae Protects against Sepsis by Inducing IgGs That Activate the Complement System
por: Corsini, Bruno, et al.
Publicado: (2021)

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
por: Repáraz, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dljtep67u27ic7udujsa7hodij